First Tracks Biotherapeutics, Inc. TRAX
46.34 USD +1.29 (+2.86%)
At closeNov 3, 2026, 4:00 PM EST
46.34 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
45.54 Day range 46.71
14.72 52-week range 49.91
- YTD
- +143.89%
- 1 year
- +143.89%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 74.17 +60.0% upside
Now 46.34
- Target (low)
- 57.00
- Target (mean)
- 74.17
- Target (high)
- 100.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
- Strong buy3
- Buy9
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.88545 | -1.01 – -0.63 | 0.00 | 0.0% | 0 | 0.0% | 10 |
| Next quarter | -0.81882 | -1.00 – -0.51 | 0.00 | 0.0% | 0 | 0.0% | 10 |
| Current year | -4.03 | -4.54 – -3.20 | 0.00 | 0.0% | 0 | 0.0% | 11 |
| Next year | -3.62 | -4.77 – -2.39 | -4.03 | +10.1% | 0 | 0.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 30, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Sep 18, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| Sep 16, 2026 | Guggenheim | Initiated | — | Buy |
| Sep 3, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 13, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 10, 2026 | UBS | Maintained | Buy | Buy |
| Jul 28, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 28, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 8, 2026 | Wells Fargo | Initiated | — | Overweight |
| May 4, 2026 | Piper Sandler | Initiated | — | Overweight |
| Apr 28, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 24, 2026 | Leerink Partners | Initiated | — | Outperform |
| Apr 23, 2026 | JP Morgan | Initiated | — | Overweight |
| Apr 22, 2026 | Barclays | Initiated | — | Overweight |
| Apr 21, 2026 | UBS | Initiated | — | Buy |